Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Pediatr Surg ; 52(4): 602-608, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28277298

ABSTRACT

PURPOSE: Ovarian torsion must be diagnosed and treated as much early as possible. The aim of the present study was to investigate effects of intraperitoneal administration of nimodipine on ischemia-reperfusion injury in ovaries. METHODS: Thirty healthy male Wistar rats weighing approximately 250g were randomized into six experimental groups (n=5): Group Sham: The rats underwent only laparotomy. Group I: A 3-h ischemia only. Group I/R: A 3-h ischemia and a 3-h reperfusion. Group I/Nimodipine: A 3-h ischemia only and 1mg/kg intraperitoneal administration of nimodipine 2.5h after induction of ischemia. Group I/R/Nimodipine: A 3-h ischemia, a 3-h reperfusion and 1mg/kg intraperitoneal administration of nimodipine 2.5h after induction of ischemia. RESULTS: Nimodipine treated animals showed significantly ameliorated development of ischemia and reperfusion tissue injury compared to those of other groups (P<0.05). The significant higher values of SOD, tGSH, GPO, GSHRd and GST were observed in I/R/Nimodipine animals compared to those of other groups (P<0.05). The damage indicators (NOS, MDA, MPO and DNA damage level) were significantly lower in I/R/Nimodipine animal compared to those of other groups (P<0.05). CONCLUSIONS: Intraperitoneal administration of nimodipine could be helpful in minimizing ischemia-reperfusion injury in ovarian tissue exposed to ischemia.


Subject(s)
Calcium Channel Blockers/administration & dosage , Nimodipine/administration & dosage , Ovarian Diseases/prevention & control , Reperfusion Injury/prevention & control , Animals , Biomarkers/metabolism , Calcium Channel Blockers/therapeutic use , Female , Injections, Intraperitoneal , Nimodipine/therapeutic use , Ovarian Diseases/metabolism , Ovarian Diseases/pathology , Ovary/metabolism , Ovary/pathology , Random Allocation , Rats , Rats, Wistar , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL